ID
int64 1
9.11k
| age
float64 18
102
| death
int64 0
1
| sex
stringclasses 2
values | hospdead
int64 0
1
| slos
int64 3
343
| d.time
int64 3
2.03k
| dzgroup
stringclasses 8
values | dzclass
stringclasses 4
values | num.co
int64 0
9
| edu
float64 0
31
⌀ | income
stringclasses 4
values | scoma
float64 0
100
⌀ | charges
float64 1.17k
1.44M
⌀ | totcst
float64 0
633k
⌀ | totmcst
float64 -102.72
711k
⌀ | avtisst
float64 1
83
⌀ | race
stringclasses 5
values | sps
float64 0.2
99.2
⌀ | aps
float64 0
143
⌀ | surv2m
float64 0
0.97
⌀ | surv6m
float64 0
0.95
⌀ | hday
int64 1
148
| diabetes
int64 0
1
| dementia
int64 0
1
| ca
stringclasses 3
values | prg2m
float64 0
1
⌀ | prg6m
float64 0
1
⌀ | dnr
stringclasses 3
values | dnrday
float64 -88
285
⌀ | meanbp
float64 0
195
⌀ | wblc
float64 0
200
⌀ | hrt
float64 0
300
⌀ | resp
float64 0
90
⌀ | temp
float64 31.7
41.7
⌀ | pafi
float64 12
890
⌀ | alb
float64 0.4
29
⌀ | bili
float64 0.1
63
⌀ | crea
float64 0.1
21.5
⌀ | sod
float64 110
181
⌀ | ph
float64 6.83
7.77
⌀ | glucose
float64 0
1.09k
⌀ | bun
float64 1
300
⌀ | urine
float64 0
9k
⌀ | adlp
float64 0
7
⌀ | adls
float64 0
7
⌀ | sfdm2
stringclasses 5
values | adlsc
float64 0
7.07
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
101 | 32.99899 | 1 | female | 1 | 10 | 10 | Cirrhosis | COPD/CHF/Cirrhosis | 2 | 19 | $25-$50k | 9 | 88,720 | 46,155.375 | null | 39.5 | other | 45.195313 | 75 | 0.397949 | 0.200989 | 1 | 0 | 0 | no | 0 | 0 | dnr after sadm | 10 | 62 | 11.599609 | 130 | 8 | 36.59375 | 296.625 | 2 | 31 | 4.199219 | 127 | 7.389648 | null | null | null | null | 0 | <2 mo. follow-up | 0 |
102 | 72.39697 | 1 | female | 0 | 4 | 26 | CHF | COPD/CHF/Cirrhosis | 2 | 10 | null | 0 | 11,588 | 6,508.8789 | null | 6 | black | 20.699219 | 29 | 0.830933 | 0.723999 | 1 | 0 | 0 | no | null | null | no dnr | 4 | 115 | 6.599609 | 104 | 20 | 37.29688 | 460 | null | null | 2.299805 | 138 | 7.549805 | null | null | null | null | 1 | <2 mo. follow-up | 1 |
103 | 66.5 | 1 | male | 0 | 12 | 539 | CHF | COPD/CHF/Cirrhosis | 2 | 10 | under $11k | 0 | 29,870 | 16,443.3594 | null | 17.5 | white | 21.898438 | 29 | 0.834961 | 0.730957 | 1 | 0 | 0 | no | 0.25 | 0.75 | no dnr | 12 | 85 | 10.898438 | 88 | 16 | 36.39844 | null | null | null | 2.299805 | 133 | null | null | null | null | 2 | 0 | no(M2 and SIP pres) | 0 |
104 | 72.78296 | 1 | male | 0 | 24 | 153 | CHF | COPD/CHF/Cirrhosis | 3 | 13 | null | 0 | 45,798 | 26,877.8594 | null | 16.666656 | white | 30.398438 | 40 | 0.66394 | 0.48999 | 1 | 0 | 0 | no | 0.8 | 0.75 | no dnr | 24 | 65 | 13.5 | 105 | 26 | 39 | 132.5 | 2.899902 | 0.5 | 1.699951 | 139 | 7.519531 | null | null | null | 2 | null | no(M2 and SIP pres) | 1.839 |
105 | 61.56897 | 0 | female | 0 | 11 | 1,958 | CHF | COPD/CHF/Cirrhosis | 2 | 8 | under $11k | 0 | 22,040 | 13,137.5078 | null | 9 | white | 11.898438 | 26 | 0.930908 | 0.882935 | 1 | 0 | 0 | no | 1 | 0.9 | no dnr | 11 | 90 | 6.5 | 80 | 20 | 36 | null | 4.699219 | 1.099854 | 1.699951 | 134 | null | null | null | null | 1 | 1 | no(M2 and SIP pres) | 1 |
106 | 52.43298 | 1 | female | 0 | 8 | 53 | Colon Cancer | Cancer | 1 | 16 | $11-$25k | 0 | 12,161 | 6,753.2773 | null | 7 | black | 16.898438 | 10 | 0.839966 | 0.649902 | 1 | 0 | 0 | metastatic | null | null | dnr after sadm | 3 | 89 | 7.899414 | 46 | 20 | 36.79688 | null | null | 0.399963 | 0.899902 | 140 | null | null | null | null | 2 | 2 | <2 mo. follow-up | 2 |
107 | 66.93195 | 0 | female | 0 | 17 | 1,955 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 12 | under $11k | 0 | 88,469 | 46,006.1562 | null | 18.666656 | black | 21.699219 | 55 | 0.755981 | 0.678955 | 4 | 0 | 0 | yes | 0.95 | 0.85 | no dnr | 17 | 141 | 22.296875 | 148 | 28 | 37.5 | 256.625 | 2.199707 | 0.799927 | 1.099854 | 142 | 7.459961 | null | null | null | null | 2 | null | 2 |
108 | 84.76697 | 1 | female | 0 | 8 | 128 | COPD | COPD/CHF/Cirrhosis | 1 | 16 | under $11k | 0 | 19,608 | 9,826.8906 | null | 14 | white | 21.699219 | 44 | 0.718994 | 0.56189 | 1 | 0 | 0 | no | 0.5 | 0.4 | no dnr | 8 | 70 | 11.5 | 75 | 50 | 36.5 | 200 | null | null | 0.799927 | 138 | 7.429688 | null | null | null | 1 | 7 | adl>=4 (>=5 if sur) | 7 |
109 | 80.172 | 1 | male | 0 | 6 | 1,730 | CHF | COPD/CHF/Cirrhosis | 2 | 8 | $11-$25k | 0 | 6,148 | 3,811.3106 | null | 9 | white | 17.296875 | 16 | 0.845947 | 0.747925 | 1 | 0 | 0 | no | 0.95 | 0.8 | no dnr | 6 | 83 | 15.898438 | 85 | 20 | 36 | 462.5 | null | 0.299988 | 1.299805 | 136 | 7.349609 | null | null | null | 0 | null | no(M2 and SIP pres) | 0.4948 |
110 | 79.96997 | 1 | male | 0 | 11 | 275 | CHF | COPD/CHF/Cirrhosis | 2 | 14 | $11-$25k | 0 | 17,554 | 10,868.0859 | null | 10 | other | 18 | 27 | 0.837891 | 0.734985 | 1 | 0 | 0 | no | null | null | no dnr | 11 | 69 | 11.199219 | 62 | 20 | 36.5 | 352.375 | null | null | 1.5 | 140 | 7.469727 | null | null | null | 0 | null | null | 0.4948 |
111 | 66.45599 | 0 | male | 0 | 12 | 1,952 | CHF | COPD/CHF/Cirrhosis | 1 | 16 | null | 0 | 25,668 | 14,813.8359 | null | 17.5 | white | 17.296875 | 11 | 0.883911 | 0.806885 | 1 | 0 | 0 | no | null | null | no dnr | 12 | 85 | 4.799805 | 70 | 20 | 36.39844 | null | 3.699707 | 1.199951 | 0.899902 | 129 | null | null | null | null | 0 | 0 | null | 0 |
112 | 58.116 | 1 | female | 1 | 4 | 4 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 12 | under $11k | 0 | 33,960 | 16,787.625 | null | 46 | white | 37.898438 | 60 | 0.534912 | 0.419983 | 2 | 0 | 0 | no | 0.2 | 0.2 | dnr after sadm | 4 | 66 | 18.898438 | 130 | 30 | 37.69531 | 81.32812 | 2.299805 | 10.5 | 0.799927 | 143 | 7.459961 | null | null | null | null | null | <2 mo. follow-up | 2.756348 |
113 | 67.49097 | 0 | male | 0 | 24 | 1,951 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | null | null | 26 | 172,597 | 87,621.75 | null | 24.666656 | white | 28.898438 | 41 | 0.527954 | 0.412964 | 9 | 0 | 0 | no | 0.9 | 0.9 | no dnr | 24 | 100 | 18.296875 | 102 | 20 | 37.39844 | 156 | 4.799805 | 1.399902 | 5.799805 | 141 | 7.469727 | null | null | null | null | null | null | 2.750977 |
114 | 52.09 | 1 | male | 0 | 11 | 35 | Cirrhosis | COPD/CHF/Cirrhosis | 3 | 8 | $11-$25k | 0 | 13,414 | 8,930.6719 | null | 7.5 | white | 21.898438 | 34 | 0.805908 | 0.68689 | 1 | 0 | 0 | no | 0.9 | 0.8 | no dnr | 11 | 89 | 6.399414 | 92 | 20 | 37.39844 | 442.8125 | 2.199707 | 10.898438 | 1.199951 | 133 | 7.429688 | null | null | null | 5 | 1 | <2 mo. follow-up | 1 |
115 | 66.59296 | 1 | male | 0 | 5 | 49 | CHF | COPD/CHF/Cirrhosis | 1 | 8 | $11-$25k | 0 | 5,872 | 3,679.9609 | null | 7 | black | 13.798828 | 36 | 0.910889 | 0.849976 | 1 | 0 | 0 | no | 0.95 | 0.8 | no dnr | 5 | 76 | 6.5 | 84 | 24 | 36.39844 | 533.25 | 3.699707 | 3.399902 | 1.599854 | 139 | 7.479492 | null | null | null | 1 | 0 | <2 mo. follow-up | 0 |
116 | 56.13998 | 0 | male | 0 | 5 | 1,949 | Cirrhosis | COPD/CHF/Cirrhosis | 1 | null | null | 0 | 6,083 | 3,908.0156 | null | 11 | white | 16.796875 | 20 | 0.850952 | 0.753906 | 1 | 0 | 0 | no | null | null | no dnr | 5 | 109 | 5.399414 | 80 | 20 | 36.59375 | null | 3 | 1.099854 | 1.899902 | 139 | null | null | null | null | null | null | null | 2.0625 |
117 | 63.76199 | 1 | male | 0 | 11 | 48 | Colon Cancer | Cancer | 2 | null | null | 0 | 7,737 | 5,288.8438 | null | 5.5 | white | 13.699219 | 11 | 0.858887 | 0.684937 | 1 | 0 | 0 | metastatic | 0.1 | 0.001 | dnr after sadm | 1 | 104 | 7.799805 | 78 | 22 | 36.59375 | null | null | null | null | 137 | null | null | null | null | null | null | <2 mo. follow-up | 2.708008 |
118 | 39.73199 | 1 | male | 0 | 8 | 394 | CHF | COPD/CHF/Cirrhosis | 1 | 12 | under $11k | 0 | 16,616 | 9,458.5 | null | 13 | black | 18.5 | 16 | 0.92688 | 0.876953 | 1 | 0 | 0 | no | 0.5 | 0.5 | no dnr | 8 | 69 | null | 112 | 22 | 37.19531 | null | null | null | 1.399902 | 137 | null | null | null | null | 6 | 4 | no(M2 and SIP pres) | 4 |
119 | 60.40198 | 0 | male | 0 | 3 | 1,944 | CHF | COPD/CHF/Cirrhosis | 2 | 16 | >$50k | 0 | 9,381 | 5,027.7227 | null | 12 | white | 12 | 9 | 0.931885 | 0.884888 | 1 | 0 | 0 | no | null | 0.75 | no dnr | 3 | 80 | 9.099609 | 106 | 18 | 37 | null | 4.299805 | 0.899902 | 1.099854 | 137 | null | null | null | null | 0 | 0 | null | 0 |
120 | 57.771 | 1 | male | 0 | 9 | 1,745 | Colon Cancer | Cancer | 1 | null | null | 0 | 25,187 | 14,744.7969 | null | 6.5 | other | 5.5 | 20 | 0.928955 | 0.833984 | 1 | 0 | 0 | metastatic | 1 | 1 | no dnr | 9 | 111 | 9.298828 | 88 | 20 | 38 | null | 4.299805 | 0.899902 | 1.5 | 138 | null | null | null | null | null | null | null | 2.093262 |
121 | 48.07397 | 1 | male | 0 | 4 | 831 | CHF | COPD/CHF/Cirrhosis | 3 | null | null | 0 | 5,570 | 3,670.0703 | null | 9 | other | 19.097656 | 39 | 0.908936 | 0.846924 | 1 | 1 | 0 | no | 0.9 | 0.7 | no dnr | 4 | 69 | 8.199219 | 88 | 28 | 36.39844 | 255 | null | null | 1.699951 | 135 | 7.5 | null | null | null | null | null | null | 2.357422 |
122 | 76.68396 | 1 | female | 1 | 58 | 58 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 12 | null | 26 | 229,314 | 109,920.375 | null | 29 | black | 25.296875 | 27 | 0.532959 | 0.417969 | 3 | 0 | 0 | yes | null | null | dnr after sadm | 44 | 84 | 24.796875 | 145 | 16 | 38.69531 | 150 | null | 0.299988 | 0.799927 | 138 | 7.509766 | null | null | null | null | 3 | <2 mo. follow-up | 3 |
123 | 78.35699 | 1 | male | 0 | 4 | 374 | CHF | COPD/CHF/Cirrhosis | 2 | 12 | null | 0 | 4,629 | 3,081.2656 | null | 7 | black | 21.398438 | 30 | 0.799927 | 0.67688 | 1 | 0 | 0 | no | null | null | no dnr | 4 | 60 | 8.599609 | 115 | 20 | 36 | 404.75 | null | null | 1.5 | 137 | 7.469727 | null | null | null | 0 | 1 | no(M2 and SIP pres) | 1 |
124 | 85.29999 | 1 | male | 1 | 4 | 4 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | null | null | 0 | 20,365 | 10,969.5312 | null | 18 | white | 24.296875 | 36 | 0.678955 | 0.584961 | 4 | 0 | 0 | no | 0.1 | 0.001 | dnr after sadm | 1 | 62 | 12.099609 | 64 | 36 | 36.89844 | 142.84375 | 2.599609 | 0.599976 | 1.299805 | 146 | 7.299805 | null | null | null | null | null | <2 mo. follow-up | 2.947266 |
125 | 62.47498 | 1 | male | 0 | 22 | 150 | CHF | COPD/CHF/Cirrhosis | 2 | 11 | $11-$25k | 0 | 68,367 | 36,036.9688 | null | 22.666656 | white | 28.398438 | 40 | 0.755981 | 0.61499 | 1 | 0 | 0 | no | 0.5 | 0.1 | no dnr | 22 | 55 | 11.298828 | 105 | 24 | 36.69531 | null | 3.299805 | 2.399902 | 1.5 | 125 | null | null | null | null | 1 | 0 | no(M2 and SIP pres) | 0 |
126 | 76.41296 | 1 | female | 0 | 4 | 449 | CHF | COPD/CHF/Cirrhosis | 2 | 6 | null | 0 | 4,386 | 2,759.834 | null | 8 | black | 21.199219 | 31 | 0.80896 | 0.691895 | 1 | 0 | 0 | no | 0.75 | 0.5 | no dnr | 4 | 113 | 3.199707 | 80 | 20 | 36.29688 | null | 3.099609 | 0.799927 | 2.199707 | 144 | null | null | null | null | null | null | adl>=4 (>=5 if sur) | 2.395996 |
127 | 45.11398 | 1 | male | 1 | 11 | 11 | Lung Cancer | Cancer | 1 | null | null | 9 | 13,100 | 7,766.0273 | null | 7.5 | black | 25.699219 | 11 | 0.518921 | 0.196991 | 1 | 0 | 0 | metastatic | null | null | dnr after sadm | 1 | 109 | 10.798828 | 98 | 18 | 36.39844 | null | 3.199707 | null | 0.599976 | 130 | null | null | null | null | null | null | <2 mo. follow-up | 3.758301 |
128 | 68.12598 | 1 | female | 0 | 5 | 460 | Cirrhosis | COPD/CHF/Cirrhosis | 2 | null | null | 0 | 6,992 | 4,581.8008 | null | 6 | black | 17.699219 | 20 | 0.779907 | 0.647949 | 1 | 0 | 0 | no | null | null | no dnr | 5 | 80 | 6.399414 | 80 | 16 | 37.19531 | 485.6875 | 2.5 | 3.399902 | 0.699951 | 133 | 7.459961 | null | null | null | null | null | null | 2.259277 |
129 | 82.17694 | 1 | female | 0 | 10 | 597 | Lung Cancer | Cancer | 1 | 15 | $25-$50k | 0 | 15,942 | 10,364.7812 | null | 13 | white | 4.5 | 17 | 0.862915 | 0.69397 | 1 | 0 | 0 | metastatic | null | null | no dnr | 10 | 90 | 17.296875 | 80 | 24 | 37.69531 | null | 4.399414 | 1 | 0.899902 | 140 | null | null | null | null | 0 | null | no(M2 and SIP pres) | 0.4948 |
130 | 41.87 | 0 | male | 0 | 15 | 1,935 | Cirrhosis | COPD/CHF/Cirrhosis | 3 | null | >$50k | 0 | 68,108 | 38,119.4688 | null | 23.333328 | white | 18.097656 | 17 | 0.875 | 0.792969 | 3 | 0 | 0 | no | 0.5 | 0.6 | no dnr | 15 | 95 | 18.296875 | 64 | 16 | 36.5 | 235 | null | 2.299805 | 1.099854 | 140 | 7.449219 | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 |
131 | 76.20795 | 1 | female | 0 | 3 | 23 | Cirrhosis | COPD/CHF/Cirrhosis | 2 | 11 | under $11k | 9 | 3,644 | 2,314.8516 | null | 5 | black | 21.5 | 29 | 0.611938 | 0.424988 | 1 | 1 | 0 | no | 0.2 | 0.008 | no dnr | 3 | 103 | 4.799805 | 90 | 20 | 37.69531 | null | null | null | 1.5 | 124 | null | null | null | null | null | 6 | <2 mo. follow-up | 6 |
132 | 60.04398 | 1 | female | 1 | 11 | 11 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 12 | under $11k | 37 | 506,141 | 272,995.25 | null | 44 | white | 29.398438 | 42 | 0.467957 | 0.348999 | 60 | 0 | 0 | no | 0.5 | 0.25 | no dnr | 11 | 67 | 1.099854 | 82 | 26 | 37.39844 | 228.875 | 4 | 1.399902 | 2.099609 | 131 | 7.399414 | null | null | null | null | 2 | <2 mo. follow-up | 2 |
133 | 77.13898 | 1 | male | 1 | 12 | 12 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 20 | $11-$25k | 0 | 159,553 | 81,082.1875 | null | 46 | white | 28.5 | 45 | 0.580933 | 0.470947 | 17 | 0 | 0 | no | null | null | dnr after sadm | 8 | 67 | 14.599609 | 94 | 24 | 36.19531 | 156.90625 | null | 1.799805 | 2.5 | 137 | 7.5 | null | null | null | null | 4 | <2 mo. follow-up | 4 |
134 | 72.96399 | 0 | female | 0 | 8 | 1,934 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 13 | $11-$25k | 0 | 42,243 | 22,744.0781 | null | 23.5 | white | 29 | 26 | 0.625 | 0.521973 | 6 | 0 | 0 | no | 0.9 | 0.8 | no dnr | 8 | 56 | 3.899902 | 69 | 20 | 38.5 | 110 | 2.599609 | null | 0.599976 | 135 | 7.349609 | null | null | null | 4 | 3 | adl>=4 (>=5 if sur) | 3 |
135 | 59.40598 | 1 | male | 0 | 9 | 96 | CHF | COPD/CHF/Cirrhosis | 2 | 12 | >$50k | 0 | 19,852 | 11,541.8047 | null | 17.5 | white | 25.199219 | 53 | 0.817993 | 0.704956 | 1 | 0 | 0 | no | 0.85 | 0.75 | no dnr | 9 | 57 | 7.599609 | 114 | 28 | 36.5 | null | 4 | 1.099854 | 2.799805 | 135 | null | null | null | null | 0 | 0 | adl>=4 (>=5 if sur) | 0 |
136 | 72.83795 | 1 | male | 1 | 109 | 109 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | null | null | 26 | 740,010 | 357,918.75 | null | 47.5 | white | 29 | 43 | 0.490967 | 0.372986 | 9 | 0 | 0 | no | null | null | dnr after sadm | 67 | 67 | 11.599609 | 95 | 18 | 38.79688 | 140 | 2.699707 | null | 3.5 | 134 | 7.469727 | null | null | null | null | null | Coma or Intub | 2.823731 |
137 | 50.23099 | 0 | female | 0 | 13 | 1,933 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | null | null | 37 | 44,480 | 24,166.0312 | null | 19.5 | white | 20.5 | 19 | 0.789917 | 0.721924 | 3 | 0 | 0 | no | 0.95 | 0.9 | no dnr | 13 | 94 | 11.898438 | 97 | 38 | 39.19531 | 204.0625 | null | null | 1.099854 | 140 | 7.429688 | null | null | null | null | null | null | 3.461426 |
138 | 71.56195 | 1 | female | 0 | 8 | 817 | Colon Cancer | Cancer | 1 | 12 | $25-$50k | 0 | 15,051 | 8,141.4531 | null | 9 | white | 5.099609 | 14 | 0.920898 | 0.814941 | 1 | 0 | 0 | metastatic | 0.95 | 0.5 | no dnr | 8 | 137 | 15.398438 | 80 | 20 | 38.5 | null | 4.399414 | null | 0.699951 | 141 | null | null | null | null | 1 | null | null | 1.1669 |
139 | 71.90399 | 1 | male | 0 | 9 | 385 | Colon Cancer | Cancer | 1 | 10 | null | 0 | 24,612 | 14,901.6641 | null | 7.5 | hispanic | 13.199219 | 20 | 0.851929 | 0.671997 | 1 | 0 | 0 | metastatic | 0.95 | 0.857 | no dnr | 9 | 106 | 13.898438 | 88 | 20 | 36 | null | 3.899902 | 0.599976 | 1.299805 | 136 | null | null | null | null | 1 | 0 | no(M2 and SIP pres) | 0 |
140 | 44.62997 | 1 | female | 1 | 6 | 6 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | null | null | 9 | 40,418 | 20,818.8438 | null | 30 | white | 21.597656 | 35 | 0.873901 | 0.829956 | 1 | 0 | 0 | no | null | null | no dnr | 6 | 78 | 28.296875 | 122 | 16 | 38.69531 | 204.4375 | 4.199219 | null | 1 | 140 | 7.5 | null | null | null | null | null | <2 mo. follow-up | 2.363281 |
141 | 51.98398 | 1 | female | 0 | 12 | 588 | Colon Cancer | Cancer | 1 | 17 | >$50k | 0 | 29,303 | 16,406.4062 | null | 17 | white | 5.199219 | 12 | 0.934937 | 0.845947 | 1 | 0 | 0 | metastatic | 0.95 | 0.857 | no dnr | 12 | 95 | 13.898438 | 64 | 18 | 37.5 | 300 | 4.599609 | 1.099854 | 0.599976 | 137 | 7.469727 | null | null | null | 0 | 1 | no(M2 and SIP pres) | 1 |
142 | 53.82599 | 1 | male | 0 | 16 | 26 | CHF | COPD/CHF/Cirrhosis | 0 | 12 | $25-$50k | 0 | 24,587 | 14,452.7344 | null | 9 | hispanic | 22.597656 | 27 | 0.865967 | 0.777954 | 1 | 0 | 0 | no | 0.85 | 0.614 | no dnr | 16 | 63 | 8 | 96 | 18 | 35.89844 | null | null | null | 1.599854 | 129 | null | null | null | null | null | null | <2 mo. follow-up | 2.606445 |
143 | 50.431 | 1 | male | 1 | 6 | 6 | MOSF w/Malig | ARF/MOSF | 3 | null | null | 26 | 70,463 | 35,895.0938 | null | 47 | white | 43 | 78 | 0.068985 | 0.024998 | 4 | 0 | 0 | yes | null | null | dnr after sadm | 6 | 54 | 12.699219 | 136 | 32 | 36.89844 | 175 | null | 7.799805 | 2.699707 | 132 | 7.189453 | null | null | null | null | null | <2 mo. follow-up | 3.104492 |
144 | 31.69099 | 1 | male | 0 | 28 | 1,167 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 14 | $11-$25k | 0 | 274,531 | 165,149 | null | 26.75 | hispanic | 34.09375 | 43 | 0.725952 | 0.641968 | 6 | 0 | 0 | no | 0.75 | 0.7 | no dnr | 28 | 140 | 13.398438 | 50 | 28 | 38.89844 | 167.5 | 3.899902 | 27.5 | 0.899902 | 137 | 7.5 | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 |
145 | 65.30896 | 1 | female | 0 | 25 | 866 | COPD | COPD/CHF/Cirrhosis | 1 | 12 | under $11k | 26 | 84,901 | 40,449.3125 | null | 16 | white | 21.898438 | 18 | 0.779907 | 0.647949 | 1 | 0 | 0 | no | 0.9 | 0.8 | no dnr | 25 | 99 | 14.599609 | 150 | 16 | 37.39844 | 348.5625 | null | null | 0.699951 | 136 | 7.469727 | null | null | null | null | null | SIP>=30 | 3.000977 |
146 | 81.54095 | 1 | male | 0 | 15 | 91 | CHF | COPD/CHF/Cirrhosis | 3 | 12 | $25-$50k | 0 | 20,850 | 13,284.5781 | null | 10 | white | 28.5 | 27 | 0.580933 | 0.387939 | 1 | 0 | 1 | yes | 0.25 | 0.1 | no dnr | 15 | 84 | 65 | 61 | 20 | 37.19531 | 359.25 | 2.299805 | null | 1.799805 | 139 | 7.449219 | null | null | null | null | 6 | null | 6 |
147 | 66.39795 | 1 | male | 0 | 6 | 106 | CHF | COPD/CHF/Cirrhosis | 1 | 16 | under $11k | 0 | 17,247 | 10,426.7891 | null | 20 | white | 15.099609 | 35 | 0.901978 | 0.835938 | 1 | 0 | 0 | no | null | 0.7 | no dnr | 6 | 59 | 6.099609 | 54 | 18 | 36.59375 | 376.1875 | 4.199219 | null | 1.5 | 134 | 7.469727 | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 |
148 | 50.20099 | 1 | male | 1 | 34 | 34 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | null | null | 0 | 218,924 | 100,290 | null | 33.75 | white | 37.5 | 63 | 0.518921 | 0.402954 | 13 | 0 | 0 | no | 0.1 | 0.001 | dnr after sadm | 16 | 60 | 3.899902 | 145 | 27 | 37.69531 | 122.5 | null | 0.5 | 3.399902 | 134 | 7.229492 | null | null | null | null | null | <2 mo. follow-up | 2.536621 |
149 | 88.29797 | 1 | male | 0 | 29 | 623 | CHF | COPD/CHF/Cirrhosis | 2 | 8 | null | 0 | 63,639 | 39,865.0938 | null | 13.25 | white | 24.5 | 41 | 0.677979 | 0.506958 | 2 | 0 | 0 | no | null | null | no dnr | 29 | 72 | 11.199219 | 80 | 26 | 37.19531 | 180 | null | null | 2 | 131 | 7.479492 | null | null | null | null | 2 | null | 2 |
150 | 58.41498 | 1 | female | 0 | 23 | 217 | Colon Cancer | Cancer | 1 | 14 | $25-$50k | 0 | 58,940 | 26,872.9688 | null | 19.666656 | white | 13.798828 | 11 | 0.86499 | 0.697998 | 1 | 0 | 0 | metastatic | 0.9 | 0.75 | no dnr | 23 | 91 | 5.099609 | 88 | 24 | 37 | null | null | 1 | 1 | 138 | null | null | null | null | null | null | null | 2.505859 |
151 | 56.34998 | 1 | female | 0 | 15 | 74 | Lung Cancer | Cancer | 2 | null | null | 0 | 26,731 | 13,389.5703 | null | 14.333328 | white | 22.597656 | 39 | 0.606934 | 0.290955 | 1 | 0 | 0 | metastatic | null | null | dnr after sadm | 7 | 67 | 7.599609 | 140 | 36 | 39 | 216.65625 | null | null | 0.799927 | 135 | 7.459961 | null | null | null | null | null | null | 3.6875 |
152 | 71.69897 | 0 | female | 0 | 5 | 1,922 | Colon Cancer | Cancer | 0 | 19 | null | 0 | 5,319 | 3,470.7637 | null | 8 | white | 17.097656 | 18 | 0.802979 | 0.579956 | 1 | 0 | 0 | metastatic | null | null | no dnr | 5 | 68 | 5.299805 | 60 | 20 | 37 | null | 3.299805 | 0.599976 | 0.899902 | 143 | null | null | null | null | 0 | null | no(M2 and SIP pres) | 0.4948 |
153 | 32.13998 | 1 | male | 1 | 27 | 27 | MOSF w/Malig | ARF/MOSF | 2 | null | null | 0 | 256,835 | 123,820.938 | null | 33.25 | other | 55.195313 | 63 | 0.006 | 0.001 | 12 | 0 | 0 | yes | 0.1 | 0.001 | no dnr | 27 | 24 | 20.199219 | 145 | 30 | 38.69531 | 222.5 | null | 1 | 2.199707 | 125 | 7.349609 | null | null | null | null | null | <2 mo. follow-up | 2.214844 |
154 | 48.10999 | 1 | female | 0 | 26 | 41 | Cirrhosis | COPD/CHF/Cirrhosis | 2 | 2 | $11-$25k | 0 | 56,562 | 31,515.375 | null | 16.75 | hispanic | 27.796875 | 42 | 0.733887 | 0.583984 | 1 | 0 | 0 | no | 0.8 | 0.4 | no dnr | 26 | 77 | 4.799805 | 92 | 30 | 36.19531 | null | null | 17.796875 | 1 | 131 | null | null | null | null | 3 | 0 | <2 mo. follow-up | 0 |
155 | 76.383 | 0 | male | 0 | 11 | 1,921 | Colon Cancer | Cancer | 1 | null | null | 0 | 24,788 | 14,783.8203 | null | 15.5 | other | 6 | 16 | 0.909912 | 0.791992 | 1 | 0 | 0 | metastatic | 0.95 | 0.75 | no dnr | 11 | 82 | 5.5 | 62 | 18 | 37 | 390.4375 | 4.299805 | 0.5 | 1 | 134 | 7.389648 | null | null | null | null | null | null | 2.262207 |
156 | 57.81 | 1 | male | 1 | 23 | 23 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 12 | under $11k | 26 | 125,797 | 58,915.1875 | null | 30 | white | 24.898438 | 36 | 0.747925 | 0.668945 | 1 | 0 | 0 | no | 0.4 | 0.3 | dnr after sadm | 8 | 113 | 20.597656 | 82 | 16 | 37 | 267.5 | null | 4.399414 | 2.699707 | 144 | 7.429688 | null | null | null | null | 0 | <2 mo. follow-up | 0 |
157 | 66.76794 | 1 | female | 0 | 11 | 657 | Colon Cancer | Cancer | 1 | 12 | null | 0 | 15,358 | 9,215.3125 | null | 9.5 | white | 14.398438 | 22 | 0.846924 | 0.661987 | 1 | 0 | 0 | metastatic | null | null | no dnr | 11 | 79 | 3.299805 | 87 | 19 | 36.5 | null | null | 0.5 | 1.299805 | 139 | null | null | null | null | 0 | null | no(M2 and SIP pres) | 0.4948 |
158 | 46.45898 | 1 | male | 0 | 7 | 414 | Colon Cancer | Cancer | 1 | 16 | >$50k | 0 | 21,906 | 12,927.0312 | null | 10 | white | 4 | 9 | 0.94397 | 0.86792 | 1 | 0 | 0 | metastatic | 0.95 | 0.75 | no dnr | 7 | 89 | 9.699219 | 80 | 20 | 37.5 | null | 4.299805 | 0.199982 | 1.099854 | 135 | null | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 |
159 | 64.34796 | 1 | female | 0 | 20 | 451 | Colon Cancer | Cancer | 1 | 12 | $11-$25k | 0 | 77,328 | 42,579.8125 | null | 16 | white | 13.298828 | 25 | 0.861938 | 0.691895 | 1 | 0 | 0 | metastatic | 0.9 | 0.75 | no dnr | 20 | 120 | 11.099609 | 112 | 28 | 38.79688 | null | 2.699707 | 0.699951 | 0.799927 | 138 | null | null | null | null | 0 | 1 | no(M2 and SIP pres) | 1 |
160 | 75.23596 | 1 | female | 0 | 12 | 539 | Colon Cancer | Cancer | 1 | 12 | $11-$25k | 0 | 26,189 | 14,225.7031 | null | 19.5 | asian | 5.099609 | 22 | 0.917969 | 0.80896 | 1 | 0 | 0 | metastatic | 0.95 | 0.75 | no dnr | 12 | 103 | 10.298828 | 90 | 20 | 37 | 628 | 4.399414 | 0.5 | 1.299805 | 137 | 7.289062 | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 |
161 | 74.60394 | 1 | male | 0 | 14 | 1,691 | ARF/MOSF w/Sepsis | ARF/MOSF | 3 | 10 | null | 0 | 58,853 | 31,826.5625 | null | 19.666656 | white | 25.097656 | 41 | 0.697998 | 0.606934 | 7 | 0 | 1 | no | 0.7 | 0.6 | no dnr | 14 | 157 | 14.699219 | 40 | 16 | 36 | 220 | null | 0.599976 | 1.799805 | 136 | 7.359375 | null | null | null | null | null | null | 4.647461 |
162 | 36.45999 | 0 | female | 0 | 33 | 1,913 | Coma | Coma | 0 | null | null | 61 | 201,322 | 112,886.875 | null | 30.75 | white | 30.398438 | 36 | 0.438965 | 0.365967 | 5 | 0 | 0 | no | null | null | no dnr | 33 | 110 | 16 | 123 | 34 | 39 | 104 | 5.699219 | null | 0.699951 | 139 | 7.5 | null | null | null | null | null | null | 2.36377 |
163 | 63.77298 | 1 | male | 1 | 21 | 21 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 16 | >$50k | 26 | 89,043 | 47,001 | null | 24 | white | 28.398438 | 24 | 0.54895 | 0.434998 | 15 | 0 | 1 | no | 0.5 | 0.15 | dnr after sadm | 17 | 71 | 11.599609 | 96 | 32 | 38 | 128.5625 | 3.599609 | 0.5 | 0.799927 | 127 | 7.479492 | null | null | null | null | null | <2 mo. follow-up | 4.415039 |
164 | 65.70599 | 1 | male | 0 | 7 | 140 | Colon Cancer | Cancer | 1 | 18 | $25-$50k | 0 | 8,729 | 4,916.8086 | null | 9.5 | hispanic | 17.398438 | 20 | 0.809937 | 0.593994 | 1 | 0 | 0 | metastatic | null | null | no dnr | 7 | 84 | 10.5 | 81 | 20 | 37.89844 | null | null | 5 | 1.199951 | 138 | null | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 |
165 | 20.83199 | 1 | male | 1 | 3 | 3 | MOSF w/Malig | ARF/MOSF | 1 | null | null | 0 | 392,950 | 197,040.125 | null | 37 | white | 88.390625 | 106 | 0 | 0 | 63 | 0 | 0 | yes | null | null | dnr after sadm | 1 | 0 | 5.799805 | 0 | 0 | 37.79688 | 130 | 4 | 10.5 | 3.599609 | 132 | 7.279297 | null | null | null | null | null | <2 mo. follow-up | 1.141602 |
166 | 52.668 | 1 | female | 1 | 13 | 13 | Coma | Coma | 0 | null | null | 94 | 104,602 | 52,896.7812 | null | 37 | white | 19.097656 | 6 | 0.422974 | 0.349976 | 6 | 0 | 0 | no | null | null | null | null | 88 | 14.898438 | 72 | 12 | 36.19531 | 277.5 | null | null | 0.5 | 138 | 7.579102 | null | null | null | null | null | <2 mo. follow-up | 2.500977 |
167 | 75.36798 | 1 | male | 1 | 13 | 13 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | null | null | 26 | 125,256 | 64,887.8125 | null | 35 | white | 30.097656 | 73 | 0.44696 | 0.326965 | 8 | 1 | 0 | no | 0.05 | 0.000125 | no dnr | 13 | 63 | 12.898438 | 60 | 4 | 37.79688 | 166 | null | 1.099854 | 8.599609 | 132 | 7.469727 | null | null | null | null | null | <2 mo. follow-up | 2.930664 |
168 | 53.86697 | 0 | male | 0 | 4 | 1,909 | CHF | COPD/CHF/Cirrhosis | 2 | 18 | null | 0 | 20,923 | 12,116.0312 | null | 6 | white | 14.199219 | 25 | 0.92395 | 0.871948 | 2 | 0 | 0 | no | null | null | no dnr | 4 | 63 | 6.5 | 68 | 26 | 36 | 400 | 3.899902 | 0.099991 | 1.299805 | 139 | 7.459961 | null | null | null | 0 | null | no(M2 and SIP pres) | 0.4948 |
169 | 44.35898 | 1 | male | 0 | 5 | 543 | CHF | COPD/CHF/Cirrhosis | 3 | 12 | $11-$25k | 0 | 12,042 | 6,767.7578 | null | 12 | white | 21.796875 | 35 | 0.895996 | 0.825928 | 1 | 0 | 0 | no | null | null | no dnr | 5 | 69 | 9.5 | 136 | 20 | 36.39844 | 261.875 | null | 0.5 | 1.599854 | 137 | 7.419922 | null | null | null | null | null | no(M2 and SIP pres) | 2.432617 |
170 | 53.62097 | 1 | female | 0 | 34 | 58 | Cirrhosis | COPD/CHF/Cirrhosis | 2 | 12 | null | 0 | 279,530 | 180,716.375 | null | 21.75 | white | 17.898438 | 21 | 0.848999 | 0.751953 | 1 | 0 | 0 | no | 0.65 | 0.4 | no dnr | 34 | 76 | 6.5 | 88 | 18 | 37.19531 | null | 2.199707 | 1.5 | 1.099854 | 128 | null | null | null | null | null | null | <2 mo. follow-up | 2.432129 |
171 | 84.90295 | 1 | female | 0 | 7 | 1,227 | Colon Cancer | Cancer | 2 | 15 | $11-$25k | 0 | 9,291 | 5,748.9297 | null | 3.5 | white | 21 | 21 | 0.705933 | 0.422974 | 1 | 0 | 0 | metastatic | 0.8 | 0.5 | no dnr | 7 | 86 | 4.799805 | 80 | 20 | 36.29688 | null | 3.099609 | 0.699951 | 1.699951 | 141 | null | null | null | null | 0 | null | no(M2 and SIP pres) | 0.4948 |
172 | 70.83899 | 1 | male | 0 | 6 | 24 | CHF | COPD/CHF/Cirrhosis | 3 | null | null | 0 | 10,955 | 6,502.7344 | null | 11 | white | 25.199219 | 46 | 0.771973 | 0.636963 | 1 | 0 | 1 | no | null | null | dnr after sadm | 2 | 68 | 10 | 61 | 39 | 37.09375 | 383.625 | null | null | 3.299805 | 133 | 7.579102 | null | null | null | null | null | <2 mo. follow-up | 4.18457 |
173 | 70.06195 | 1 | male | 0 | 11 | 266 | CHF | COPD/CHF/Cirrhosis | 4 | 12 | under $11k | 0 | 15,687 | 10,228.8594 | null | 11 | hispanic | 24 | 43 | 0.793945 | 0.668945 | 1 | 1 | 0 | no | 0.85 | 0.7 | no dnr | 11 | 111 | 7.399414 | 80 | 16 | 35.89844 | 304.75 | 3.199707 | 1.399902 | 2.699707 | 134 | 7.479492 | null | null | null | 0 | 1 | SIP>=30 | 1 |
174 | 37.71899 | 1 | male | 1 | 7 | 7 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 13 | null | 26 | 268,805 | 132,976.5 | null | 48 | white | 37.59375 | 78 | 0.442993 | 0.323975 | 48 | 0 | 0 | no | 0.1 | 0.001 | null | null | 61 | 0.099991 | 140 | 45 | 39.09375 | 238 | null | 0.799927 | 2.799805 | 148 | 7.429688 | null | null | null | null | 1 | <2 mo. follow-up | 1 |
175 | 65.45697 | 1 | female | 1 | 19 | 19 | Lung Cancer | Cancer | 1 | 13 | $11-$25k | 0 | 41,397 | 23,832 | null | 12 | black | 14.398438 | 21 | 0.754883 | 0.497986 | 1 | 0 | 0 | metastatic | 0.45 | 0.2 | dnr after sadm | 17 | 90 | 18.898438 | 68 | 18 | 36.19531 | 285.6875 | 3.799805 | 0.699951 | 1 | 134 | 7.459961 | null | null | null | 0 | 5 | <2 mo. follow-up | 5 |
176 | 29.88399 | 1 | female | 0 | 33 | 34 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 16 | >$50k | 26 | 223,581 | 103,008.562 | null | 28.75 | white | 34 | 30 | 0.550903 | 0.437988 | 9 | 0 | 0 | yes | 0.8 | 0.8 | dnr after sadm | 33 | 81 | 10.599609 | 118 | 20 | 38 | 95 | 2.599609 | 6 | 0.599976 | 135 | 7.389648 | null | null | null | null | 2 | <2 mo. follow-up | 2 |
177 | 87.521 | 1 | female | 0 | 90 | 1,530 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | null | null | 0 | 469,824 | 232,752.25 | null | 32.25 | white | 30.199219 | 54 | 0.47699 | 0.357971 | 12 | 0 | 0 | no | null | null | no dnr | 90 | 127 | 15.5 | 120 | 34 | 37.79688 | 75 | 2.099609 | 0.099991 | 1.199951 | 134 | 7.469727 | null | null | null | null | null | null | 3.319336 |
178 | 18.146 | 0 | male | 0 | 85 | 1,899 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 12 | $11-$25k | 26 | 641,888 | 328,378.5 | null | 43.25 | hispanic | 40.195313 | 87 | 0.625977 | 0.522949 | 1 | 0 | 0 | no | 0.8 | 0.8 | no dnr | 85 | 44 | 2 | 142 | 27 | 37.19531 | 314.25 | 1.899902 | 0.299988 | 10.699219 | 134 | 7.349609 | null | null | null | null | 0 | Coma or Intub | 0 |
179 | 42.92398 | 1 | male | 1 | 20 | 20 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | null | null | 26 | 277,421 | 133,680.875 | null | 33 | white | 36.796875 | 70 | 0.426941 | 0.307983 | 54 | 0 | 0 | no | null | null | dnr after sadm | 9 | 63 | 32.59375 | 132 | 50 | 39.5 | 77.32812 | 2.099609 | null | 1.5 | 135 | 7.209961 | null | null | null | null | null | <2 mo. follow-up | 3.061035 |
180 | 37.396 | 1 | female | 1 | 17 | 17 | Cirrhosis | COPD/CHF/Cirrhosis | 3 | 13 | $11-$25k | 0 | 166,927 | 86,323.875 | null | 43.666657 | black | 26.5 | 51 | 0.730957 | 0.577881 | 5 | 0 | 0 | yes | null | null | dnr after sadm | 16 | 73 | 5.899414 | 120 | 24 | 37.09375 | 233.3125 | null | null | 3.199707 | 132 | 7.40918 | null | null | null | null | null | <2 mo. follow-up | 2.849121 |
181 | 63.46899 | 1 | male | 0 | 12 | 1,023 | Colon Cancer | Cancer | 1 | null | null | 0 | 29,732 | 16,300.9844 | null | 16.5 | white | 7.299805 | 23 | 0.912964 | 0.79895 | 1 | 0 | 0 | metastatic | 0.95 | 0.8 | no dnr | 12 | 124 | 5.399414 | 118 | 20 | 37.39844 | 313.3125 | 4.699219 | 0.799927 | 0.799927 | 133 | 7.419922 | null | null | null | null | null | null | 2.17627 |
182 | 53.57999 | 1 | female | 0 | 5 | 1,572 | COPD | COPD/CHF/Cirrhosis | 1 | null | null | 0 | 5,132 | 2,881.541 | null | 9 | white | 17.398438 | 31 | 0.92395 | 0.870972 | 1 | 0 | 0 | no | null | null | no dnr | 5 | 93 | 12.398438 | 92 | 12 | 36.59375 | 256 | null | 0.299988 | 1.099854 | 136 | 7.519531 | null | null | null | null | null | null | 2.358398 |
183 | 70.07495 | 1 | male | 0 | 20 | 324 | CHF | COPD/CHF/Cirrhosis | 1 | 11 | $11-$25k | 0 | 33,290 | 18,993.5312 | null | 12.333328 | black | 16.199219 | 22 | 0.884888 | 0.807983 | 1 | 0 | 0 | no | null | null | no dnr | 20 | 80 | null | 90 | 18 | 36.79688 | null | 4.099609 | null | 2 | 132 | null | null | null | null | 0 | 1 | null | 1 |
184 | 47.633 | 1 | female | 1 | 3 | 3 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | null | null | 0 | 138,674 | 71,315.3125 | null | 15 | asian | 70.09375 | 83 | 0 | 0 | 21 | 0 | 0 | no | 0.05 | 0.000125 | dnr after sadm | 2 | 25 | 4.5 | 125 | 10 | 36 | 167.34375 | null | 32.398438 | 3.599609 | 142 | 7.5 | null | null | null | null | null | <2 mo. follow-up | 1.694092 |
185 | 51.54797 | 1 | male | 0 | 37 | 466 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 10 | null | 0 | 170,244 | 79,871.5 | null | 24 | white | 28.898438 | 32 | 0.659912 | 0.56189 | 10 | 0 | 0 | yes | 0.25 | 0.0156 | no dnr | 37 | 65 | 17.597656 | 126 | 29 | 37.89844 | 165 | null | null | 0.599976 | 132 | 7.469727 | null | null | null | null | 2 | no(M2 and SIP pres) | 2 |
186 | 90.83899 | 1 | female | 0 | 14 | 708 | CHF | COPD/CHF/Cirrhosis | 1 | 12 | null | 0 | 14,065 | 8,867.6719 | null | 8.333328 | white | 17.296875 | 28 | 0.80896 | 0.690918 | 1 | 0 | 0 | no | 0.5 | 0.25 | dnr after sadm | 1 | 100 | 10.898438 | 82 | 22 | 36.19531 | 210 | null | null | 1 | 145 | 7.519531 | null | null | null | null | null | null | 3.875977 |
187 | 35.625 | 1 | female | 1 | 3 | 3 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | null | null | 0 | 23,421 | 12,434.3672 | null | 39 | black | 50.296875 | 80 | 0.356995 | 0.23999 | 1 | 0 | 0 | no | null | null | no dnr | 3 | 25 | 19.796875 | 150 | 28 | 37.19531 | 309.5 | null | null | 2.5 | 135 | 7.15918 | null | null | null | null | null | <2 mo. follow-up | 2.098633 |
188 | 63.85999 | 1 | female | 1 | 5 | 5 | Coma | Coma | 0 | null | null | 94 | 47,424 | 25,078.2031 | null | 15 | white | 20.296875 | 22 | 0.280945 | 0.211975 | 5 | 0 | 0 | no | null | null | null | null | 139 | 8.298828 | 122 | 10 | 38.69531 | 350 | null | null | 0.699951 | 149 | 7.529297 | null | null | null | null | null | <2 mo. follow-up | 2.530762 |
189 | 67.04199 | 1 | male | 0 | 31 | 1,216 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 10 | $11-$25k | 9 | 100,735 | 55,332.7812 | null | 13 | white | 20 | 35 | 0.790894 | 0.7229 | 7 | 0 | 0 | no | 0.98 | 0.95 | no dnr | 31 | 129 | 9.398438 | 125 | 36 | 38 | 272.5 | 3.199707 | null | 1 | 138 | 7.489258 | null | null | null | null | 0 | adl>=4 (>=5 if sur) | 0 |
190 | 61.16098 | 0 | female | 0 | 106 | 1,889 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 12 | null | 9 | 970,982 | 39.496 | null | 38.25 | white | 30.597656 | 56 | 0.571899 | 0.460999 | 29 | 0 | 0 | no | 0.5 | 0.5 | no dnr | 106 | 66 | 14.699219 | 105 | 20 | 36.5 | 274 | 3.199707 | 6.099609 | 2.599609 | 134 | 7.40918 | null | null | null | null | null | adl>=4 (>=5 if sur) | 2.803711 |
191 | 77.13098 | 1 | male | 0 | 5 | 465 | Lung Cancer | Cancer | 3 | null | null | 0 | 29,403 | 5,321.5938 | null | 17 | white | 16.597656 | 33 | 0.687988 | 0.395996 | 1 | 0 | 0 | metastatic | null | null | no dnr | 5 | 62 | 5.599609 | 82 | 12 | 36.39844 | 276.1875 | null | null | 1.199951 | 135 | 7.429688 | null | null | null | null | null | null | 2.981445 |
192 | 19.14 | 0 | male | 0 | 56 | 1,889 | CHF | COPD/CHF/Cirrhosis | 1 | 12 | $25-$50k | 0 | 216,359 | 134,573.25 | null | 15.75 | white | 20.597656 | 21 | 0.944946 | 0.905884 | 1 | 0 | 0 | no | null | null | no dnr | 56 | 61 | 8.5 | 108 | 26 | 36.5 | null | 4.299805 | 1.099854 | 0.899902 | 125 | null | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 |
193 | 64.18097 | 1 | male | 0 | 11 | 683 | Colon Cancer | Cancer | 2 | 14 | $11-$25k | 0 | 26,311 | 13,976.2734 | null | 16.5 | white | 11.199219 | 21 | 0.881958 | 0.73291 | 1 | 1 | 0 | metastatic | 0.9 | 0.75 | no dnr | 11 | 100 | 9.298828 | 120 | 18 | 37.5 | null | 4.299805 | 1.099854 | 0.799927 | 133 | null | null | null | null | 1 | 0 | no(M2 and SIP pres) | 0 |
194 | 53.30298 | 0 | female | 0 | 9 | 1,887 | Colon Cancer | Cancer | 1 | null | null | 0 | 17,823 | 8,599.2031 | null | 10.5 | white | 20.5 | 12 | 0.789917 | 0.556885 | 1 | 0 | 0 | metastatic | 0.95 | 0.9 | no dnr | 9 | 89 | 10.199219 | 120 | 20 | 39.69531 | null | null | 0.399963 | 0.699951 | 138 | null | null | null | null | 2 | null | no(M2 and SIP pres) | 1.839 |
195 | 55.28799 | 1 | female | 0 | 9 | 91 | CHF | COPD/CHF/Cirrhosis | 2 | 13 | null | 0 | 19,419 | 11,965.4844 | null | 13 | white | 24.699219 | 38 | 0.799927 | 0.677979 | 1 | 0 | 0 | yes | 0.8 | 0.2 | no dnr | 9 | 59 | 5.799805 | 145 | 20 | 37 | 456.625 | 2.899902 | 0.799927 | 0.899902 | 133 | 7.369141 | null | null | null | null | null | no(M2 and SIP pres) | 3.123047 |
196 | 53.14697 | 1 | male | 0 | 6 | 1,162 | CHF | COPD/CHF/Cirrhosis | 2 | 14 | null | 0 | 16,552 | 9,827.4219 | null | 20 | asian | 10.5 | 23 | 0.948975 | 0.911987 | 1 | 0 | 0 | no | 0.8 | 0.4 | no dnr | 6 | 75 | 6.699219 | 72 | 18 | 36.09375 | null | 4.699219 | 2.799805 | 1.099854 | 136 | null | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 |
197 | 32.44098 | 1 | male | 0 | 281 | 386 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 11 | null | 37 | 1,273,347 | 633,212 | null | 38.5 | white | 32.296875 | 44 | 0.569946 | 0.458984 | 58 | 0 | 0 | no | 0.3 | 0.3 | no dnr | 281 | 51 | 16.699219 | 96 | 30 | 37.39844 | 108.5625 | 2.399902 | 1 | 0.699951 | 143 | 7.509766 | null | null | null | null | 7 | Coma or Intub | 7 |
198 | 58.95999 | 0 | female | 0 | 26 | 1,882 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 13 | $25-$50k | 9 | 207,902 | 121,042.438 | null | 23 | white | 23.398438 | 17 | 0.748901 | 0.669922 | 19 | 0 | 0 | no | 0.8 | 0.75 | no dnr | 26 | 115 | 6.199219 | 132 | 20 | 39.79688 | 326.625 | null | null | 0.599976 | 136 | 7.5 | null | null | null | null | 0 | adl>=4 (>=5 if sur) | 0 |
199 | 27.411 | 0 | male | 0 | 27 | 1,881 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | null | null | 26 | 122,322 | 63,008.5625 | null | 18.5 | white | 22 | 40 | 0.879883 | 0.837891 | 1 | 0 | 0 | no | 0.5 | 0.8 | no dnr | 27 | 78 | 27.597656 | 130 | 8 | 38.5 | 228 | 2.599609 | 1.599854 | 0.699951 | 137 | 7.529297 | null | null | null | 0 | 1 | null | 1 |
200 | 77.09497 | 1 | male | 0 | 9 | 248 | CHF | COPD/CHF/Cirrhosis | 2 | 16 | >$50k | 9 | 23,862 | 13,112.5312 | null | 17.5 | white | 22.097656 | 30 | 0.768921 | 0.631958 | 1 | 1 | 0 | no | 0.3 | 0.1 | no dnr | 9 | 93 | 11.599609 | 86 | 22 | 36.59375 | null | null | null | 3.399902 | 137 | null | null | null | null | 3 | 0 | null | 0 |